home / stock / cdtx / cdtx articles


CDTX Articles, Cidara Therapeutics Inc. - From 04/22/24

Stock Information

Company Name: Cidara Therapeutics Inc.
Stock Symbol: CDTX
Market: NASDAQ
Website: cidara.com

Menu

CDTX CDTX Quote CDTX Short CDTX News CDTX Articles CDTX Message Board
Get CDTX Alerts

News, Short Squeeze, Breakout and More Instantly...

Why Cidara Therapeutics (CDTX) Stock Is Falling | Benzinga

Cidara Therapeutics Inc (NASDAQ:CDTX) shares are trading lower by 24.4% to $0.52 Monday afternoon. The company announced a 1-for-20 reverse stock s...

Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024 | Benzinga

- Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonst...

Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO | Benzinga

Approval triggered by positive results from ReSTORE Phase III clinical trial Payment will advance Cidara's Cloudbreak platform for the devel...

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress | Benzinga

SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&#...

Cidara Therapeutics Presents New Preclinical and Clinical Data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023 | Benzinga

SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&#...

Cidara to Present at the 25th Annual H.C. Wainwright Global Investment Conference | Benzinga

SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&...

Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher | Benzinga

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.57% to 34,44...

Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide l...

Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? | Benzinga

Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of&...

Previous 10 Next 10